Viruses like Lassa fever and COVID-19 disrupt the immune system in ways we’re just beginning to understand. Scripps Research postdoc Jyothi Purushotham, PhD, studies how these interactions drive severe disease and uncover pathways for new therapies. More: ow.ly/ZAAQ50UuxCS

Our new essay The Lancet on certifying generalist medical #AI systems, from a template of the training process in medicine thelancet.com/journals/lance… Pranav Rajpurkar

A new report on the impact of Paxlovid on treating long COVID, with comments from Julia MV.

In this Viewpoint, Josip Car and Eric Topol call upon academic institutions, industry stakeholders, and policymakers to collaborate in developing and adopting a Master of Digital Health with specializations. #MedEd ja.ma/40Anl0D

Great news from our NCATS #CTSAProgram partner!

5 years since the start of the COVID-19 pandemic Julia MV reminds us not to forget the lessons learned. usnews.com/opinion/articl…

A Q&A with Julia MV on her long COVID journey and what she would do if she was appointed the national long COVID czar. The San Diego Union-Tribune Paul Sisson sandiegouniontribune.com/2025/03/17/a-q…

New #SCL podcast: Project scientist Josh Levy @[email protected] and PhD student Praneeth Gangavarapu explain how wastewater surveillance helps detect viruses like SARS-CoV-2, H5N1 & seasonal flu—sometimes before outbreaks spread. 🎧 Listen now: ow.ly/F6Tm50VlZoH

Our nature paper today on multimodal generative #AI for interpretation of medical images and generating reports across many specialties nature.com/articles/s4158… Pranav Rajpurkar Vish Rao

Online now: Immunological drivers of zoonotic virus emergence, evolution, and endemicity dlvr.it/TJsdh5

🎧 Download 🆕 episode of #NFIDPodcast #InfectiousIDeas, with #SpecialGuest Eric Topol Scripps Research discussing revolutionary impacts of AI in medicine and healthcare Listen, like, and subscribe: ow.ly/TRX450VsAhx

Here's what is exciting about the science of aging. nytimes.com/2025/04/21/opi… New York Times Opinion

Ali Torkamani joined KUSI News this morning to discuss his latest Nature Medicine study on a better way to predict a patient’s risk of coronary artery disease using #AI. youtube.com/watch?v=Eh5H2J…

Here is the final version of our research demonstrating that providing at-home COVID-19 tests, along with on-demand telemedicine and rapid prescription delivery can reduce COVID ICU stays in immunocompromised people (more info at bsky) bsky.app/profile/julial…

Interested in STEM and want to learn about collaboration between academic institutes and industry? Join us at San Diego State University on June 3 for a networking event and seminar. Find out more and register at - scripps.edu/science-and-me…

Thanks to San Diego State University for hosting yesterday’s Perspectives in STEM seminar and networking event where we learned about the importance of collaboration, communication and mentorship when pursuing careers in academia and industry.

We can predict a person's risk of coronary artery disease better than ever before. Cover of new Nature Medicine regarding our Scripps Research Translational Institute Scripps Research recent paper Ali Torkamani nature.com/articles/s4159…

The future of personalized medicine is a lot closer than you think! ⌚️💊 At the Scripps Research Digital Trials Center (Scripps Research Digital Trials Center), scientists are reimagining how clinical studies are done, using wearable devices, smartphone apps, and at-home biosample kits to gather data on

🚨 Long COVID patients 🚨Our team is working with the Schmidt Initiative for Long COVID and CareEvolution to launch a clinical trial to investigate the efficacy of a repurposed drug for treating Long COVID. Learn more and sign up for notifications. silc.org/news/at-home-p…

Scientists at Scripps Research Digital Trials Center describe an AI model that can detect hidden diabetes risk by analyzing data from continuous glucose monitors, alongside gut microbiome, diet, physical activity and genetic information. Nature Medicine scripps.edu/news-and-event…